H.PIO Co., Ltd. (KOSDAQ:357230)
South Korea · Delayed Price · Currency is KRW 2,130.00
+75.00 (3.65%)
At close: Jul 31, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 87.4 billion as of August 3, 2026. Its market cap has decreased by -13.04% in one year.
Market Cap
87.40B
Enterprise Value
97.18B
Revenue
266.01B
Ranking
n/a
PE Ratio
9.10
Stock Price
2,130.00
ChartMarket Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 87.40B, a decrease of -73.83%. That is a compound annual growth rate of -22.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 87.40B | -12.50% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ahn-Gook Pharmaceutical | 113.20B |
| High Tech Pharm | 109.95B |
| DongKoo Bio & Pharma | 99.92B |
| HYUNDAI BIOLAND | 96.90B |
| OPTUS Pharmaceutical | 96.35B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |
| KOREA PHARMA | 76.67B |